Trial Profile
Phase 2: Effects of Rosuvastatin on Surrogate Markers for Cardiovascular Events in Patients With Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders; Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- Acronyms RORA
- 11 Jun 2008 Results presented at the 2008 Annual European Congress of Rheumatology.
- 06 Jun 2008 New trial record.